Stay updated on ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Sign up to get notified when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.

Latest updates to the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new version entry (Revision: v3.6.6) dated 2026-08-28 was added to the history, and the previous revision (v3.6.5) was removed; this introduces an updated Study Status in the record timeline.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe record history adds a new revision entry v3.6.5 and removes the previous v3.6.4 entry, reflecting an update to the page's revision history.SummaryDifference0.0%

- Check52 days agoChange DetectedThe history now shows a new site revision (v3.6.4) replacing the previous revision (v3.6.3), indicating a recent software release for the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check66 days agoChange DetectedA new Study Status entry was added to the record history (noted on 2026-07-02 with 120 items) and an older entry dated 2026-06-05 was removed. This updates the visible history of the trial’s status and its historical record.SummaryDifference0.1%

- Check73 days agoChange DetectedThe record history now shows the page revision updated to v3.6.3, replacing the previous v3.6.2, reflecting an underlying platform update rather than changes to study content.SummaryDifference0.0%

- Check80 days agoChange DetectedFooter now displays Revision: v3.6.2, replacing v3.6.0. This indicates a recent software update applied to the page.SummaryDifference0.0%

Stay in the know with updates to ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.